Trials / Conditions / Measles-Mumps-Rubella Vaccine
Measles-Mumps-Rubella Vaccine
3 registered clinical trials studyying Measles-Mumps-Rubella Vaccine.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine NCT02184572 | GlaxoSmithKline | Phase 3 |
| Completed | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vac NCT01681992 | GlaxoSmithKline | Phase 3 |
| Completed | Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months o NCT00861744 | GlaxoSmithKline | Phase 2 |